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Postsynaptic site 
The cellular and subceilular distribution of a major cyclic AMP binding protein in the central nervous ystem, the neural-specific regulatory 
subunit of the type II cyclic AMP-dependent protein kinase (RII-B), was analyzed in rat brains with light and electron microscopic 
immunocytochemical methods. The distribution of the non-neural isoform of the regulatory subunit of the enzyme (RII-H) was also analyzed. 
It was found that RII-B immunoreactivity was predominantly localized to neurons whereas glial and endothelial cells were unlabeled. In the 
neurons the RII-B immunoreactivity occurred in the perikaryal cytoplasm and in the dendrites; there was no significant accumulation of
immunoreaction product in nuclei, myelinated axons and axon terminals. Although immunoreactivity was never detected in axon terminals, 
it was characteristically associated with the postsynaptic densities and the surrounding non-synaptic sites in somata, dendrites and dendritic 
spines. The localization of RII-B antigenic sites did not show specificity to any type of neuron or synapse, but the amount of immunoreaetivity 
varied. The distribution of RII-H immunoreactivity was similar to that of RII-B except hat RII-H immunoreaction product was also observed 
in glial cells and occurred more frequently in myelinated axons. Our data confirm that RII-B is one of the major cyclic AMP binding proteins 
in neurons, and provide morphological support for the involvement of the type II cyclic AMP-dependent protein kinase in postsynaptic neural 
functions. 
INTRODUCTION 
Second messenger systems, such as the cyclic AMP 
(cAMP) system, play an important, though not com- 
pletely understood role in the regulation of synaptic 
transmission in the central nervous system ae'23. Indeed, 
extracellular application of membrane-permeant ana- 
logues of cAMP affects the synaptic excitability in 
vitro 13'2° and can induce marked behavioral and electro- 
graphic effects in vivo 8A8"19. Although some electrophy- 
siological data show that cAMP can act directly on ion 
channels 12, the only known receptor proteins that medi- 
ate the effects of cAMP in the brain are the regulatory 
subunits of the cAMP-dependent protein kinases 
(cAMPdPK)  17"34. It has also been shown that two major 
categories of cAMP binding proteins exist: RI and RII,  
the regulatory subunits of the type I and type II 
cAMPdPK,  respectively 22"23. 
Since the brain contains ignificantly more of the type 
I1 cAMPdPK than the type I kinase TM and specific 
destruction of neurons by intracerebrai injection of kainic 
acid depleted selectively the type II cAMPdPK 35, RI I  
seems to be a major candidate for mediating the effects 
of cAMP in neurons in the central nervous system. In 
addition, Erl ichman et al. found that RI I  in the brain was 
immunologically distinct from the form present in skel- 
etal muscle, liver, kidney and heart 6. Further biochemical 
studies have confirmed that there are two subclasses of 
RII: a neural-specific and a non-neural isoform, RII-B 
and RI I -H,  respectively 33. RI I -B and RI I -H are the 
products of related but distinct genes 32'36. Consequently, 
clarifying the functions of RII-B in synaptic processes is 
necessary for understanding the role of the cAMP signal 
transduction system in the brain. 
An immunocytochemical analysis of the cellular and 
subcellular distribution of RI I  can provide important data 
for understanding the role of cAMPdPK.  To date, only 
the non-neural isoform has been examined with immu- 
nocytochemical methods in the brain. It was shown that 
RI I -H immunoreactivity occurs in both neuronal and glial 
elements 3'5. The intensity of RI I -H staining varied from 
cell to cell but within a stained neuron it was concen- 
trated in the dendrites and perikaryon 4'5. Subcellularly, 
RI I -H seems to be accumulated on microtubules, micro- 
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tubule-organiz ing centers and in the area of  the Golgi  
complex  5. Its presence within the nucleus was unclear,  
because posit ive and negat ive immunosta in ing were both 
repor ted  depending on whether  unfixed 3 or fixed 5 tissue 
preparat ions were used. 
In the present study we have demonstrated the cel lular 
and subcel lular distr ibution of R I I -B  immunoreact iv i ty  in 
rat brains with light and electron microscopic methods.  
We also examined the distr ibution of  R I I -H  immunore-  
activity to determine whether  any differences exist in the 
local izat ion of  these cAMP binding proteins. 
MATERIALS AND METHODS 
A total of 20 adult Sprague-Dawley rats (180-240 g), both males 
and females, were used in this study. A part of the animals (n = 14) 
was utilized for methodological tests to determine the optimal 
immunocytochemical procedure for revealing the specific RII-B or 
RII-H tissue antigens. The following parameters were analyzed: (1) 
staining pattern in both fixed and unfixed tissue; (2) staining 
intensity after the use of different fixatives; (3) staining pattern in 
both frozen and non-frozen tissue; and (4) signal-to-noise ratio 
following both overnight and 1-h incubation with the primary 
antibody. Subsequent tothese tests, experiments were conducted on 
6 rats with the procedure that provided optimal results. Details on 
this latter method are given in light and electron microscopic 
immunocytochemistry sections. 
Antibodies 
The RII-B antibody used in this study was prepared and 
characterized, as described previously 6'33. Briefly, the RII-B sub- 
units were purified from bovine cerebral cortex by a combination of 
ion exchange chromatography on DEAE-cellulose and affinity 
chromatography on 8-(6-aminohexyl) amino-cAMP-Sepharose 4B. 
The antisera to highly purified RII-B were prepared in New Zealand 
white rabbits. Specificity to obtained antisera against RII-B was 
determined by: (1) indirect immunoprecipitation; (2) competitive 
displacement radioimmunoassay; and (3) Western immunoblot 
analysis. 
The RII-H antibody was prepared and characterized, asfollows. 
Peptide P13 (IIe-Val-Ser-Pro-Thr-Thr-Phe-His-Thr-Gin-Glu-Ser- 
Ser), representing residues 35-48 of the murine RII-H 29, was 
synthesized on an Advanced Biosystems Ab 430 solid-phase peptide 
synthesizer as previously described 28. Cleavage from the resin was 
achieved by incubation in 75% HF/25% anisole for 30 min at 0 °C. 
The amount and composition of the peptide was determined by 
amino acid analysis using Waters Picotag system, and amino acid 
sequence analysis of P13 was performed on a Beckman 890C 
liquid-phase peptide sequinator. Peptide P13 was covalently coupled 
to the carrier protein rabbit serum albumin using carbodiimide. The 
antiserum was prepared in New Zealand white rabbits. A high titer 
of antiserum was obtained, and 10 ng of RII-H was detected with 
an antiserum dilution of 1:1000. No immunoreactivity toward RII-H 
was detected with the preimmune serum. 
Tissue preparation 
The rats were anesthetized (ketamine, 70 mg/kg-xylazine, 6 
mg/kg; i.p.) and transcardially perfused with 100 ml of 0.1 M 
phosphate buffered saline (PBS), pH = 7.4, followed by 450 ml of 
freshly prepared paraformaldehyde (4%) and glutaraldehyde 
(0.1%) in PBS. The brains were removed and cut into 3 mm-thick 
blocks which were postfixed in 1% paraformaldehyde overnight. 
Coronal sections (40/~m) were cut with a vibratome, and they were 
collected in PBS and processed for either light or electron 
microscopic immunocytochemistry. Thus, adjacent sections from 
the same specimen could be analyzed at both light microscopic and 
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ultrastructural levels. These analyses focused on the following areas: 
cerebral cortex, hippocampus, thalamus and the midbrain including 
the inferior colliculus. 
Light microscopic immunocytochemistry 
The sections were transferred onto gelatin-coated glass-slides on 
which the immunocytochemical procedure was conducted. Each 
section was framed by a thin Plexiglas ring (1.8 mm diameter) that 
was sealed with G-S hypo-tube cement (Germanow-Simon Corpo- 
ration). The ring surrounded the entire section to form a barrier so 
that only a small amount of incubation fluid (450/~1) was required 
for each step per section. The immunostaining procedure involved 
the following incubation steps: (1) 20% normal goat serum and 
0.25% Triton X-100; 30 min; (2) 1:500 dilution of RII-B or RII-H 
antibody and 2% normal goat serum; 60 min; (3) 1:200 dilution of 
biotinylated anti-rabbit IgG; 60 min; (4) 1% avidin: biotinylated 
horseradish peroxidase complex; 60 min; and (5) 0.05% diamino- 
benzidine and 0.01% H202; 4 min. Each step was separated from 
each other by a 15-min wash in PBS and all the solutions were made 
up in PBS. The slides were dehydrated through a series of alcohol 
solutions and coverslipped after removal of the rings by a razor 
blade. They were then viewed with a light microscope and examined 
with a MCID computerized image analysis system (Imaging Re- 
search, Inc.). 
Electron microscopic imrnunocytochemistry 
The staining procedure for electron microscopic immunocyto- 
chemistry was the same as that for the light microscopic studies 
except that free-floating sections were incubated. The immuno- 
stained specimens were dehydrated in ethanol and embedded in 
Epon 812. Serial thin sections were cut on a Sorvall ultramicrotome 
in the silver interference color range. The thin sections were 
mounted on formvar-coated slot grids, counterstained with lead 
citrate and uranyl acetate and examined with the electron micro- 
scope. 
Control immunocytochemistry 
In each experiment control studies were run parallel to the RII-B 
and RII-H immunocytochemistry to determine whether any artifacts 
were superimposed on the specific staining. In these studies, the 
primary antibodies were replaced with non-immune rabbit serum. 
Otherwise all the procedures were the same as described above. In 
addition, Nissl staining was used for some adjacent sections to 
determine the proportion of cellular elements labeled with the 
primary antisera. 
RESULTS 
The methodologica l  tests showed that the use of  
f ixative was essential to obtain informat ion about  the 
cel lular and subcel lular distr ibution of R I I -B .  A l though 
immunoreact ion  product  occurred in unf ixed tissue pro- 
cessed for R I I -B  immunocytochemist ry ,  cel lular e lements  
were almost unrecognizable.  However ,  the general  stain- 
ing pattern was not signif icantly affected by using 
relatively mild (4% paraformaldehyde)  or stronger (4% 
para formaldehyde-0 .2% glutaraldehyde) f ixation. Simi- 
larly, the distr ibution of R I I -B  was basically identical in 
both frozen and unfrozen tissue. Free-f loat ing and 
s l ide-mounted sections displayed the same staining. 
Surprisingly the factor that profoundly  affected the 
immunocytochemica l  results was the incubation t ime with 
the pr imary antibody. It was found that long (overnight)  
incubation with either pr imary ant ibodies resulted in 
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artifacts and consequently a low signal-to-noise ratio, as 
compared to sections that were incubated for a short, 1-h 
period. This shorter incubation period decreased signifi- 
cantly the amount of artifactual immunoreactivity (Fig. 1) 
and thus a high signal-to-noise ratio was obtained with 
this method. 
Light microscopic observations 
Sections incubated with RII-B antibody displayed 
specific immunostaining in all of the brain regions 
examined. For example, all layers of the cerebral cortex 
displayed immunoreaction product except for the under- 
lying white matter (Fig. 1B). The amount of immuno- 
staining for RI I -B in the white matter was at a similar 
level as that found throughout the control sections 
incubated with non-immune serum (Fig. 1). The staining 
intensity for RI I -B, as it was determined by computerized 
image analysis, was higher in the cerebral cortex, 
hippocampus, and thalamus than in the midbrain includ- 
ing the inferior colliculus, indicating that the regional 
distribution of RI I-B was not homogeneous. It is inter- 
esting to note that in the hippocampus the immunoreac- 
tion product was more concentrated in the dendritic 
layers than in the cellular layers (Fig. 4A). 
At higher magnification, the RI I -B immunostaining 
was observed in many neurons in each brain region. As 
predicted from the lack of immunostaining in the white 
matter, myelinated axons and glial cells did not appear to 
display RI I -B immunostaining. The blood vessels of the 
neuropil also did not seem to contain specific immuno- 
reactivity. In all of the brain regions examined, a 
consistent finding was that RI I -B immunoreactivity was 
localized to the perikaryal cytoplasm and the proximal 
dendritic processes of the neurons (Fig. 2). The neuronal 
nuclei were always negative for RI I -B staining (Figs. 2 
and 3). The staining pattern did not seem to be specific 
Fig. 1. Photomicrographs of two adjacent coronal sections through the parietal cortex incubated with either non-immune rabbit serum (A) 
or RII-B antiserum (B). Aside from a few red blood cells, the section incubated in non-immune serum (A) lacks staining in both the gray 
(GM) and white matter (WM). In contrast the section incubated in RII-B antiserum (B) displays immunoreaction product in the gray matter 
(GM) whereas the white matter (WM) lacks immunoreactivity. Scale bar for A and B = 100 ~m. 
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Fig. 2. Photomicrographs of RII-B immunostained sections from the same rat showing layer III of the parietal cortex (A), posterior thalamic 
nuclear group (B), central nucleus of the inferior colliculus (C) and suprapyramidal blade of the dentate gyrus (D). The immunostaining is 
prominent within neuronal somata (arrows) and their proximal dendrites, and is also found within small processes in the neuropil. Note the 
variation of the amount of immunoreaction product distributed in the labeled neurons; both strongly (thick arrows) and lightly (thin arrows) 
labeled cells are present in the same section. In the dentate gyrus (D), for example, the granule cells (thin arrow) are less densely 
immunostained than a hilar neuron (thick arrow). Scale bar for A-D = 25 gm. 
for any particular neuron type. In the cerebral cortex 
both pyramidal  and non-pyramidal (e.g. bipolar) 25 neu- 
rons were stained (Fig. 2A). In the thalamus RII-B 
staining was detected in the characteristic, scattered small 
neurons 7 and in some medium-size, multipolar neurons 
of the posterior nuclear group (Fig. 2B). In the inferior 
colliculus the medium-size, round GABAerg ic  neurons 27 
and the large, disc-shaped non-GABAerg ic  neurons both 
displayed RII-B immunoreactivity (Fig. 2C). In the 
hippocampal formation all neuronal types were immu- 
nostained, including the granule cells, the basket cells 
and the hilar neurons of the dentate gyrus 1'31 (Fig. 2D) 
and the pyramidal cells of the CA1 (Fig. 3B) and CA3 
regions (Fig. 4A). Most dendrites of these cells were 
uniformly labeled except for the CA3 pyramidal  cells that 
displayed more dense immunostaining in the dendritic 
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Fig. 3. Photomicrographs of RII-B immunostained sections from layer III of parietal cortex (A) and CA1 region of the hippocampus (B). The 
immunostaining is concentrated in the proximal apical dendrites (open arrows), whereas the neuronal nuclei (curved arrows) lack 
immunoreaction product. Scale bar for A and B = l0/~m. 
portions found in the stratum lucidum. 
The regional distribution of RI I-H immunoreactivity 
was similar to that of RII-B. However, in certain areas 
such as the hippocampus, differences were observed: the 
stratum lucidum of CA3 region displayed more dense 
RII-B than RII-H immunostaining (Fig. 4). As in the 
case of RII-B staining, the RII-H immunoreaction 
product occurred predominantly in neurons. It should be 
noted, however, that cellular profiles resembling astro- 
cytes revealed by glutamate dehydrogenase histo- 
chemistry 16 were often observed in RII-H-stained sec- 
tions, although these glial elements were much less 
densely labeled than the neurons. 
Electron microscopic observations 
At the ultrastructural level the RII-B immunoreactiv- 
ity was exclusively found to be associated with neuronal 
elements; no evidence could be detected for the presence 
of RII-B antigenic sites in glial cells. As was predicted 
from the light microscopic results, RII-B immunoreaction 
product was accumulated throughout he neuronal so- 
mata, whereas the nuclei, including the nuclear enve- 
lopes, and the nucleoli displayed no immunoreactivity 
(Figs. 5 and 7B). The immunoreaction product in the 
somata was evenly distributed in the perikaryal cyto- 
plasm. However, the overall staining intensity varied 
from soma to soma. For example, the somata of the large 
pyramidal cells of layer V of the parietal cortex were 
markedly more densely stained than that of the granule 
cells of the dentate gyrus (Figs. 5 and 7). It should be 
noted that neurons negative for RII-B immunoreactivity 
were also found in the analyzed brain regions. The 
immunoreaction product was not preferentially associ- 
ated with any organelles in the perikarya because it was 
localized to cisternae of the granular endoplasmic reti- 
culum, Golgi complex, microtubules and the outer 
membranes of the mitochondria (Figs. 5 and 7B). 
The most remarkable characteristic of the subcellular 
distribution of the RII-B antigenic sites was their asso- 
ciation with postsynaptic structures. Independent of the 
brain region where the specimens were obtained, the 
immunoreaction product was localized predominantly to
postsynaptic structures including somata and their prox- 
imal dendrites, distal dendrites found in the neuropil, and 
dendritic spines (Figs. 5-8), whereas it was rarely 
observed in myelinated axons. However, the immunore- 
activity localized to postsynaptic structures did not 
display a specificity for any particular type of synapse. 
For example, the axon terminals in the inferior colliculus 
containing either round vesicles and forming asymmetric 
synapses or flattened vesicles and forming symmetric 
synapses 26 were both apposed by dendrites that were 
positive for RII-B immunoreactivity (Fig. 8). In addition, 
the postsynaptic sites were labeled with immunoreaction 
product in both somata and dendrites (Figs. 5-8). It is 
important to note that the immunoreaction product in the 
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Fig. 4. Photomicrographs of two adjacent sections from the CA3 region of the hippocampus incubated with either RII-B (A) or RII-H (B) 
antisera. Dense immunostaining occurs in the stratum lucidum (SL), especially in comparison to the superficial dendritic zone (at top of 
photomicrographs), whereas the stratum pyramidale (SP) displays less dense staining. Note, that RII-B immunostaining is more dense in SL 
than the RII-H immunostaining. Scale bar for A and B = 50/~m. 
dendrites and somata was concentrated not only at the 
postsynaptic densities, but also at the non-synaptic parts 
of the membrane and in the adjacent cytoplasm, and 
appeared frequently as interconnected chains of small 
granules (Figs. 5-8). 
In our experimental conditions axon terminals never 
displayed RII-B immunoreactivity no matter whether 
they contained round or flattened vesicles or were 
apposed to dendrites or somata (Figs. 5-8). This is well 
reflected in the fact that in the dentate gyrus, a system 
where the neurons and their processes could be identi- 
fied, the somata and dendrites of the granule cells 
displayed RII-B immunoreactivity (Fig. 7B), but their 
axon terminals, the mossy fibers in the hilus, lacked 
immunoreaction product (Fig. 7C). 
The lack of RII-B immunoreactivity in gliai cells was 
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Fig. 5. Electron micrographs of an RII-B stained preparation obtained from the parietal cortex. A: RII-B positive pyramidal cell. The 
immunoreaction product is localized to the perikaryon (white arrows) and the proximal dendrite (d). The nucleus (N) lacks immunostaining. 
Black arrowhead points to an axo-somatic synapse. B: enlargement of the axo-somatic synapse (arrowhead) from A. An axon terminal (t) forms 
a symmetric synapse. C shows the difference in staining between the perikaryal cytoplasm (arrowheads) of an unlabeled glial cell (G) and a 
neuron. The nucleus of the neuron (N) is unstained. Scale bars = 0.5/~m. 
clearly indicated by the absence of immunoreaction 
product in either the cell bodies and processes of 
astrocytes (Fig. 5C) or in the myelin sheath of myelinated 
axons (Figs. 6C and 7A). lmmunoreaction product was 
rarely detected within myelinated axons. Also, the 
endothelial cells surrounding the capillaries displayed no 
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Fig. 6. Electron micrographs of thin sections obtained from two parietal cortex specimens stained with either RII-B antiserum (A and C) or 
non-immune rabbit serum (B). Note the dense RII-B immunostaining in dendrites (d) and dendritic spines (s) in A, whereas no specific 
immunoreaction ca  be found in B. Axon terminals (t) in both A and B do not display immunoreaction product. C: an endothelial cell (arrows) 
of a capillary (ca) and neighboring myelinated axons (a) lack RII-B immunoreactivity. However, RII-B immunoreaction product is present 
within a dendrite (d). Scale bars = 0.5/~m. 
immunoreaction product (Fig. 6C). 
The subcellular distribution of RI I -H immunoreactiv- 
ity showed many similarities with the distribution of 
RII-B immunostaining. Thus, RI I -H immunoreactivity 
was detected mainly in postsynaptic structures: in neu- 
ronal somata and dendrites (Fig. 9C). The cell nuclei 
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Fig. 7. Electron micrographs of RII-B-stained preparations from the stratum radiatum of CA1 region of the hippocampus (A), stratum 
granulosum (B) and hilus (C) of the dentate gyrus. Note the immunostained, parallel dendrites (d 1, d 2 and d3) and the unstained myelinated 
axon (a) in A. B: a granule cell with immunoreaction product in its perikaryal cytoplasm (arrows) and in its proximal dendrite (d), whereas 
its nucleus (N) is unstained. C: a terminal of a mossy fiber (mf) that originates from a granule cell, forms a synapse with a dendrite (d) and 
a dendritic spine (s) of a hilar neuron. Immunoreactivity is localized in the dendrite and spine. Scale bars = 0.5/~m. 
lacked this type of immunoreact ion  product and the 
endothel ia l  cells were also negative. However ,  some 
important  dif ferences were also observed. Among these 
was the occurrence of R I I -H  immunoreact ion  product  in 
some glial cell bodies and processes (Fig. 9A).  Also,  
immunoreact ion product  within myel inated axons was 
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Fig. 8. Electron micrographs of RII-B-stained preparations obtained from the central nucleus of the inferior coUiculus. A: an axon terminal 
(t) that contains round vesicles (arrow) forms an asymmetric synapse with a dendrite (d). B: another axon terminal (t) that contains flattened 
vesicles (arrow) forms a symmetric synapse with a dendrite (dl). Note that the immunoreaction product is localized to the dendrites with some 
association to the postsynaptic densities. In dendrite d 2 the immunoreaction product is apparently not associated with a synaptic density. A 
dendrite, negative for immunostaining (d3)  , is also present. Scale bars = 0.5 #m. 
frequently detected (Fig. 9B). 
Electron microscopic specimens obtained from sec- 
tions adjacent to the RII-B or RI I -H immunostained 
sections but incubated with non-immune rabbit serum did 
not display immunoreaction product (Fig. 6B). This 
showed that the above-described characteristics of the 
localization of RII-B or RI I -H immunoreaction product 
reflected specific antigen-antibody binding sites and 
artifacts were probably not superimposed on the specific 
immunocytochemical staining patterns. 
DISCUSSION 
In this study the cellular and subcellular distribution of 
RII-B, the neural specific regulatory subunit of the type 
II cAMPdPK and one of the major cAMP-binding 
proteins, was studied in rat brains. The main data of this 
combined light and electron microscopic immunocyto- 
chemical analysis can be summarized as follows: (1) 
RII-B antigenic sites occurred in all of the studied brain 
regions but the regional distribution of the antigenic sites 
was heterogeneous; (2) RII-B immunoreaction product 
was predominantly localized to neurons; even though a 
number of processes in the neuropil at the light micro- 
scopic level contained specific immunoreactivity, these 
were determined to be dendrites in electron microscopic 
preparations and not glial or endothelial cells; (3) RII-B 
immunoreactivity was found in all types of neurons, but 
the amount of immunoreaction product varied from 
neuron to neuron; (4) RII-B immunoreactivity was 
concentrated in neuronal somata and dendrites, whereas 
the nuclei did not contain immunoreaction product; (5) 
RII-B immunoreactivity rarely occurred in myelinated 
axons and was never found in axon terminals; and (6) 
RII-B immunoreaction product was associated with the 
postsynaptic densities, although it was not specific to any 
type of synapse and was also found at adjacent non- 
synaptic sites. 
The fact that RII-B immunoreactivity was detected in 
all the studied brain regions is consistent with the results 
of recent autoradiographic studies which described 
[3H]cAMP binding sites throughout he brain 1°. How- 
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Fig. 9. Electron micrographs ofan RII-H stained preparation obtained from the central nucleus of the inferior colliculus. A: a glial cell (G) 
with RII-H immunoreaction product (white arrows) in its cytoplasm. B: some myelinated axons (a) display RII-H immunostaining. C: an 
immunostained dendrite (d) forms a synapse with an axon terminal (t) that lacks immunoreaction product. Scale bars = 0.5/zm. 
ever, the regional distribution of RII-B immunoreactivity 
did not match consistently with that of [3H]cAMP binding 
sites. For example, our results showed that RII-B immu- 
noreactivity in the hippocampus was more concentrated in 
the dendritic layers than in the cellular layers. In contrast, 
radioactive labeling with [3H]cAMP to identify all of the 
cAMP binding proteins howed more intense binding in the 
cellular layers 1°. This supports the notion that RII-B 
represents a unique subset of cAMP binding proteins. 
In previous tudies Western immunoblot data showed 
that astrocyte membranes also displayed RII-B immuno- 
reactivity 33. In our experimental conditions, however, 
RII-B antibodies labeled only neuronal elements; possi- 
ble antigenic sites in glial elements were below the 
detectable level. This confirms that RII-B might reflect 
an adaptation of the type II cAMPdPK to the specialized 
metabolic and functional roles of neurons  6"32'33'36. In 
addition, these data show that the wide variety of effects 
of cAMP observed in glial cells 15 are probably transduced 
through cAMP binding proteins other than RII-B, 
namely RII-H or RI. Consistent with this notion is the 
observation that RII-H occurred often in glial cells in the 
present study. 
The finding that virtually all neuron types contained 
RII-B immunoreaction product, regardless of their mor- 
phological, neurochemical or electrophysiological char- 
acteristics, underscores that RII-B participates in many 
common intraneuronal processes. However, the remark- 
able variation among the individual neurons in terms of 
the accumulation of RII-B immunoreaction product is 
worth noting. This finding may indicate that different 
neurons utilize the RlI-B-linked molecular machinery to 
a different extent, depending on their function, and may 
explain the often contradictory results obtained with 
externally applied cAMP analogues onto neurons z°,24'3°. 
In addition, the heterogeneous distribution of RII-B 
immunostaining in the apical dendrites of CA3 pyramidal 
cells suggests that certain synapses may require different 
amounts of RII-B for their function. 
The main characteristics of the intraneuronal distribu- 
tion of RII-B immunoreactivity were basically similar to 
that of RII-H described in a previous tudy by De Camilli 
et al. 5. Thus, RII-B immunoreactivity was accumulated 
in the neuronal somata and dendrites and not in nuclei. 
The lack of detectable levels of RII-B and RII-H 
immunoreactivity in nuclei supports the current notion 
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that the regulatory functions of cAMP on gene 
transcription 9'21 require the presence of only the catalytic 
subunit of cAMPdPK in the nucleus. 
The principal finding of this study is that RII-B is 
associated with postsynaptic, and not with presynaptic, 
structures. This is reflected in the fact that RII-B 
immunoreaction product was accumulated in the neuro- 
nal somata, dendrites and dendritic spines, was rarely 
observed in axons, was never detected in axon terminals 
and was apparently associated with postsynaptic densi- 
ties. The less frequent occurrence of RII-B antigenic sites 
in axons than that of RI I -H may also indicate the 
significance of the concentration f RII-B in postsynaptic 
elements. These data may provide a morphological basis 
for the involvement of cAMPdPK in several postsynaptic 
neural functions, including the regulation of receptors 
and ion channels, which have been suggested by a 
number of electrophysiological and biochemical experi- 
ments 11,14,2o,24. 
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